Biogen BIIB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.42B+5.9% | $1.34B-16.6% | $1.61B+5.1% | $1.53B+3.5% | $1.48B-9.4% | ||
| $801.1M+2.7% | $779.9M+2.1% | $763.7M+2.6% | $744.3M+5.0% | $708.9M+5.3% | ||
| $293.8M+1.0% | $290.8M-5.1% | $306.3M+0.9% | $303.7M+1.4% | $299.4M+2.8% | ||
| $2.59B+17.5% | $2.2B-10.1% | $2.45B+15.9% | $2.12B-18.0% | $2.58B-10.2% | ||
| $167.9M+9.2% | $153.8M+3.1% | $149.2M+8.1% | $138M-4.8% | $144.9M-5.7% | ||
| -$1.53B-11.8% | -$1.37B-768% | -$158M+87.9% | -$1.3B-67.1% | -$780.5M+2.3% | ||
| -$322.7M-6.9% | -$301.9M-83.1% | -$164.9M-299% | -$41.3M+85.0% | -$274.8M+60.3% | ||
| —— | —— | $2.14B— | —— | —— | ||
| $2.42B+18.1% | $2.05B-11.0% | $2.3B+16.5% | $1.98B-18.8% | $2.44B-10.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Biogen generate?
- Biogen (BIIB) generated $2.6B in operating cash flow over the trailing twelve months.
- What is Biogen's free cash flow?
- After $167.9M of capital expenditures, Biogen's free cash flow was $2.4B over the trailing twelve months, down 0.6% year over year.
- Where does Biogen's cash flow data come from?
- Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
